Literature DB >> 28250293

Depressive Symptoms and Coping Behaviors among Individuals with Irritable Bowel Syndrome in Japan.

Norio Sugawara1, Ken Sato, Ippei Takahashi, Ryu Satake, Shinsaku Fukuda, Shigeyuki Nakaji, Norio Yasui-Furukori.   

Abstract

Objective Irritable bowel syndrome (IBS) is associated with a high prevalence of psychological disorders. Coping, which is used to manage stressful events, can have adaptive or maladaptive effects on a patient's health status. However, these coping behaviors have not been well studied in individuals with IBS. The association between the use of coping behaviors and the reported levels of depressive symptoms was examined in individuals with IBS. Methods Among 993 volunteers (382 men and 611 women) who participated in the Iwaki Health Promotion Project in 2013, we included 58 subjects who fulfilled the Rome III criteria for IBS in our analysis. Coping behaviors were assessed using the Brief Scale for Coping Profile (BSCP). The Center for Epidemiologic Studies Depression Scale (CES-D) was used to assess the four dimensions of depressive symptoms (depressed affect, somatic symptoms, interpersonal problems, and lack of positive affect) and the prevalence of probable depression using a cut-off score of 16. Results Among the 58 subjects with IBS, 22 (36.1%) exhibited probable depression. After adjustment for confounders, "active solution" was found to be significantly associated with somatic symptoms. Under the same conditions, "avoidance and suppression" was significantly associated with the CES-D total score, depressed affect, somatic symptoms, and (lack of) positive affect. There were no other significant relationships between depressive symptoms and the BSCP sub-scale scores. Conclusion These findings indicate that coping behaviors may influence the experience of depressive symptoms among individuals with IBS. Psychological therapy may reduce depressive symptoms as well as the severity of IBS symptoms. Additional studies are needed to examine the relationships between coping behaviors and depressive symptoms using a longitudinal study design.

Entities:  

Mesh:

Year:  2017        PMID: 28250293      PMCID: PMC5399198          DOI: 10.2169/internalmedicine.56.7695

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


Introduction

Irritable bowel syndrome (IBS) is a common gastrointestinal disorder with a prevalence 3-20% based on the Rome III criteria (1-4). This functional bowel disease involves recurrent abdominal discomfort or pain associated with alterations in the bowel (5,6). Although the etiology of IBS remains elusive, there is support for the notion that a dysfunction of the brain-gut pathways contributes to the presentation of this disease (7). According to recent studies, up to 60% of IBS patients have psychiatric disorders such as depression, anxiety, and somatization (8,9). Although IBS is a non-life threatening disorder, chronic discomfort and pain place a heavy burden on patients with IBS. Stressful events have been shown to be significant predictors of depressive symptoms, and coping behaviors can play an important role in individual well-being (10,11). Coping has been described as a process in which cognitive or behavioral strategies are developed to manage specific internal and/or external sources of psychological stress (12,13). To date, several studies have reported an association between coping behaviors and psychological symptoms among patients with IBS (14-16). Failure to cope with or adjust to stressful events may cause depression among patients with IBS. However, no studies have examined the potential link between coping behaviors and depressive symptoms among individuals with IBS in Japan. In the present study, we aimed to investigate the prevalence of depressive symptoms and to assess the relationship between coping behaviors and depressive symptoms among individuals who were diagnosed with IBS according to the Rome III criteria. We hypothesized that passive coping behaviors, such as emotional expression, avoidance and suppression, would be associated with depressive symptoms.

Materials and Methods

Participants

This study included 58 individuals with IBS who were recruited from the local community. A total of 993 volunteers (382 men and 611 women) participated in the Iwaki Health Promotion Project in 2013. We included the subjects who fulfilled the Rome III criteria for IBS in our analysis (17). The characteristics of the study population have been reported previously (18). IBS was diagnosed based on the Japanese version of the Rome III Questionnaire, when a participant reported that they had experienced recurrent abdominal pain or discomfort for at least three days per month in the last three months together with two or more of the following conditions: 1) the alleviation of symptoms with defecation, 2) the onset of symptoms occurred in association with a change in the stool frequency and 3) the onset was associated with a change in the form (appearance) of the stool. The collection of data for the present study was approved by the ethics committee at the Hirosaki University School of Medicine, and all subjects provided their written informed consent before participating in this project. The patients' demographic data (age, sex, amount of education, and marital status) and medical history were obtained from self-reported questionnaires and interviews.

The assessment of depressive symptoms

The Japanese version of the Center for Epidemiologic Studies Depression Scale (CES-D) as administered to all of the participants to measure their depressive symptoms (19). The CES-D is a 20-item self-reported measure that focuses on the depressive symptoms that the patient experienced during the week prior to completing the questionnaire. The maximum score is 60, with higher scores indicating more severe depressive symptoms. Probable depression (CES-D 16 depression) was considered to be present when a subject reported a CES-D score of ≥16. Studies in which factor analyses were performed have found the 20-item CES-D to be a multidimensional instrument that measures as many as four correlated but distinct factors (19,20). The four underlying factors were labeled by Radloff as follows: depressed affect, somatic symptoms, interpersonal problems, and (lack of) positive affect.

The assessment of coping behaviors

We employed the Brief Scale for Coping Profile (BSCP) to assess coping behaviors. The BSCP consists of 18 items rated on a 4-point scale (21,22). The participants were asked to indicate the frequency at which they used the strategy described by a particular item, ranging from 1 (almost never) to 4 (very often) in stressful situations. The scale assesses an individual's ability to cope in response to daily stressful circumstances using six sub-scales, “active solution (AC)”, “seeking help for a solution (S)”, “changing mood (CM)”, “emotional expression involving others (EE)”, “avoidance and suppression (AV)”, and “changing one's point of view (CV)”. These six sub-scales reflected three different coping dimensions: problem-focused (AC and S), adaptive emotion-focused (CM and EE), and maladaptive emotion-focused (AV and CV) coping strategies. A high score on a certain sub-scale indicates that the respondent frequently selected that coping method.

Statistical analysis

The data are presented as the mean ± standard deviation. p values of <0.05 were considered to indicate statistical significance. Pearson's correlation was used to explore the relationships between the psychological variables. All variables with a p value of <0.10 on a Pearson's correlation analysis were subsequently analyzed via a multivariate regression analysis, which was performed to assess the relationship between depressive symptoms and coping behaviors. Regression analyses were adjusted for confounding factors (age, gender, level of education, and marital status). The data were analyzed using the PASW Statistics software program for Windows, version 23.0.

Results

The characteristics of the participants

The characteristics of the study subjects with IBS are shown in Table 1. Thirteen of the 58 (22.4%) cases were categorized as IBS with constipation (IBS-C) subtype, 9 (15.5%) were categorized as IBS with diarrhea (IBS-D) subtype, and 15 (25.9%) were categorized as mixed IBS (IBS-M) subtype. Among the 58 subjects with IBS, 19 (32.8%) exhibited CES-D 16 depression.
Table 1.

Characteristics of the Subjects with Irritable Bowel Syndrome.

n%
GenderMale1932.8
Female3967.2
MarriedYes3763.8
No2136.2
Mean±SD
Age(years)49.917.5
Amount of education (years)12.02.0
Depressive symptoms (CES-D score)12.19.0
Depressed affect3.33.4
Somatic symptoms4.23.7
Interpersonal problems0.51.0
(Lack of) Positive affect4.12.9
Coping profile (BSCP score)9.12.7
Active solution8.12.9
Seeking help for solution8.02.2
Changing mood4.41.9
Emotional expression involving others6.22.3
Avoidance and suppression8.32.5
Changing a point of view49.917.5

CES-D: Center for Epidemilogic Studies Depression Scale,

BSCP: Brief Scales for Coping Profile

Characteristics of the Subjects with Irritable Bowel Syndrome. CES-D: Center for Epidemilogic Studies Depression Scale, BSCP: Brief Scales for Coping Profile

Pearson's correlations between the psychological variables

Table 2 shows the correlations between depressive symptoms and the BSCP sub-scale scores. “Active solution” showed tended to be associated with somatic symptoms but did not reach statistical significance (p=0.096). “Seeking help for solution” almost showed a statistically significant association (p=0.052) with (lack of) positive affect.“ Avoidance and suppression” were significantly associated with the CES-D total score, depressed affect, somatic symptoms, and (lack of) positive affect.
Table 2.

Correlation between Depressive Symptoms and Coping Profile among Subjects with Irritable Bowel Syndrome.

CES-D total scoreDepressed affectSomatic symptomsInterpersonal problems(Lack of) Positive affect
Active solution0.0940.0430.2210.072-0.058
Seeking help for solution-0.168-0.184-0.016-0.108-0.257
Changing mood0.1400.1080.1740.0370.079
Emotional expression involving others0.0570.1500.0290.138-0.078
Avoidance and suppression0.490**0.441**0.474**0.2470.341**
Changing a point of view0.1930.1410.2150.1300.125

CES-D: Center for Epidemilogic Studies Depression Scale

**p<0.01, *p<0.05, †p<0.10

Correlation between Depressive Symptoms and Coping Profile among Subjects with Irritable Bowel Syndrome. CES-D: Center for Epidemilogic Studies Depression Scale **p<0.01, *p<0.05, †p<0.10

The multiple regression analysis of the association between depressive symptoms and the BSCP sub-scale scores

Table 3 shows the results of the multiple regression analysis to determine the depressive symptoms that were associated with the BSCP sub-scale scores. After adjustment for confounders “active solution” was significantly associated with somatic symptoms. Under the same condition, “avoidance and suppression” was significantly associated with the CES-D total score, depressed affect, somatic symptoms, and (lack of) positive affect. There were no other significant relationships between depressive symptoms and the BSCP sub-scale scores.
Table 3.

Multiple Regression Analysis with Predictive Variables.

Multiple regression statisticsMultiple regression statistics
BSEβt valuep valueBSEβt valuep value
ACTIVE SOLUTION SEEKING HELP FOR SOLUTION
Somatic symptoms(Lack of) Positive affect
Age-0.020.03-0.07-0.490.630Age0.000.02-0.01-0.060.950
Gender-1.851.13-0.24-1.630.109Gender-1.580.83-0.26-1.900.063
Amount of education-0.150.26-0.09-0.600.552Amount of education-0.370.19-0.26-1.940.058
Married-0.181.07-0.02-0.170.864Married0.800.780.141.020.311
Active solution0.420.20.312.14<0.05Seeking help for solution-0.160.13-0.16-1.230.225
AVOIDANCE AND SUPPRESSION
CES-D total scoreDepressed affect
Age0.010.070.020.160.870Age0.000.030.020.160.873
Gender-2.602.43-0.14-1.070.289Gender-0.750.95-0.11-0.790.431
Amount of education-0.900.56-0.20-1.620.112Amount of education-0.270.22-0.16-1.240.220
Married1.492.270.080.660.515Married0.250.890.040.280.784
Avoidance and suppression2.000.480.504.19<0.001Avoidance and suppression0.670.190.453.57<0.01
Somatic symptomsInterpersonal problems
Age0.010.030.030.210.832Age-0.020.01-0.28-1.930.059
Gender-0.691.03-0.09-0.670.505Gender0.210.270.110.780.440
Amount of education-0.070.24-0.04-0.280.780Amount of education-0.170.06-0.36-2.680.010
Married0.480.960.060.500.620Married0.010.260.000.020.981
Avoidance and suppression0.770.200.483.82<0.001Avoidance and suppression0.100.050.231.830.073
(Lack of) Positive affect
Age0.020.020.100.720.476
Gender-1.370.78-0.23-1.770.083
Amount of education-0.390.18-0.28-2.220.031
Married0.760.730.131.050.300
Avoidance and suppression0.460.150.363.04<0.01

CES-D: Center for Epidemilogic Studies Depression Scale

Multiple Regression Analysis with Predictive Variables. CES-D: Center for Epidemilogic Studies Depression Scale

Discussion

The present study investigated the prevalence of probable depression, as measured by the CES-D, and assessed the relationship between coping behaviors and depressive symptoms among individuals with IBS using a cross-sectional study design. In this study, the prevalence of CES-D 16 depression among individuals with IBS was 32.8%. The prevalence of CES-D 16 depression in our study was within the range of previous results (16-39%) (2,9,23,24). After adjustment for confounders, “active solution” coping behaviors were significantly associated with somatic symptoms. This association might indicate that the somatic symptoms of IBS evoke problem-focused coping strategies. Under adjusted conditions, “avoidance and suppression” coping behaviors were also significantly associated with the CES-D total score, depressed affect, somatic symptoms, and (lack of) positive affect. “Avoidance and suppression” coping behaviors are characterized by a tendency to escape or consciously push down any undesirable thoughts. This coping behavior has been reported to be associated with increased self-blame and to potentially lead to poor psychological adjustment (25). To date, psychological distress has been thought to play a major role in IBS, although it remains to be determined how this distress is related to IBS and which of the two conditions (psychological distress or IBS) appears first. Recently, a bidirectional communication network between the central nervous system and the gastrointestinal tract has been suggested as a conceptual model of IBS. In the bottom-up model, brain functions are secondarily influenced by visceral symptoms from the gastrointestinal tract. Conversely, in the top-down model, psychological factors influence physiological factors, such as the motor, sensory, secretory, and immune functions of the gastrointestinal tract (7). Early life stressors such as maternal separation and sexual abuse have been reported to be associated with the development of IBS (26-28). Understanding the psychological problems of IBS patients could contribute to the development of effective treatments. Previous studies have documented associations between coping behaviors and depressive symptoms among individuals with IBS. Pinto et al. first reported that IBS patients with depression tend to use predominantly negative coping styles, such as passivity, fatalism and escape-avoidance (29). Another study showed that higher levels of passive behavioral coping are associated with more severe depression among individuals with IBS (30). Stanculete et al. showed that IBS patients use problem-focused and avoidance-oriented coping strategies more frequently than healthy subjects (16). These researchers also clarified that the impact of IBS symptoms on health-related quality of life is mediated by irrational beliefs and avoidance-oriented coping. Furthermore, Grodzinsky et al. reported that IBS patients reported lower scores for positive self-esteem and coping ability assessed by sense of coherence than control (15). Recently, a relationship between cognitive appraisal and depression has been reported in patients with IBS (31,32). In cognitive behavioral therapy (CBT), a patient with depression whose coping behaviors are likely to promote depression is taught new coping skills in a structured manner (33). The present results indicating that “avoidance and suppression” coping behaviors are associated with depressive symptoms may be utilized to design an evidence-based CBT approach to treat depressive patients with IBS. Current studies in clinical psychiatry have shown that CBT is as effective as antidepressant drug therapy in the treatment of patients with depression (34,35). Furthermore, clinical evidence has indicated that CBT could improve IBS symptoms (36). This study is associated with several notable limitations. First, the assessment of depressive symptoms was based on the CES-D rather than clinician-administered structured diagnostic interviews according to established criteria such as the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). The second limitation of this study was the recruitment strategy, which involved the recruitment of individuals with IBS from the community. These individuals may not be representative of clinical IBS patients. The severity of IBS or depressive symptoms among our participants might be lower than that among clinical IBS patients. Third, the data on several potential confounding factors were not obtained because of strict ethical considerations and a reluctance to share medical information. This limitation is important, as interpersonal relationships between family members and the severity of IBS symptoms may have influenced the results of this study. Finally, this study is limited by its cross-sectional design; thus, we cannot determine a causal relationship between the coping behaviors and the onset of depressive symptoms among the patients in our study population. A follow-up survey is needed to investigate these associations. In conclusion, “avoidance and suppression” was significantly associated with depressive symptoms. These findings indicate that coping behaviors may affect depressive symptoms among individuals with IBS. Furthermore, IBS patients might benefit from psycho-educational interventions such as CBT, which are designed to assist them in reducing their “avoidance and suppression” behaviors when coping with the symptoms of their illness. Additional studies using a longitudinal study design are needed to examine the relationships between coping behaviors and depressive symptoms among IBS patients.
  35 in total

1.  Cognitive appraisal and psychological distress among patients with irritable bowel syndrome.

Authors:  Menachem Ben-Ezra; Yaira Hamama-Raz; Sharon Palgi; Yuval Palgi
Journal:  Isr J Psychiatry Relat Sci       Date:  2015       Impact factor: 0.481

2.  Dynamics of a stressful encounter: cognitive appraisal, coping, and encounter outcomes.

Authors:  S Folkman; R S Lazarus; C Dunkel-Schetter; A DeLongis; R J Gruen
Journal:  J Pers Soc Psychol       Date:  1986-05

Review 3.  Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model.

Authors:  Cristina Stasi; Massimo Rosselli; Massimo Bellini; Giacomo Laffi; Stefano Milani
Journal:  J Gastroenterol       Date:  2012-07-06       Impact factor: 7.527

4.  Evidence-based clinical practice guidelines for irritable bowel syndrome.

Authors:  Shin Fukudo; Hiroshi Kaneko; Hirotada Akiho; Masahiko Inamori; Yuka Endo; Toshikatsu Okumura; Motoyori Kanazawa; Takeshi Kamiya; Ken Sato; Toshimi Chiba; Kenji Furuta; Shigeru Yamato; Tetsuo Arakawa; Yoshihide Fujiyama; Takeshi Azuma; Kazuma Fujimoto; Tetsuya Mine; Soichiro Miura; Yoshikazu Kinoshita; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2014-12-12       Impact factor: 7.527

5.  Coping strategies and interpersonal support in patients with irritable bowel syndrome and inflammatory bowel disease.

Authors:  Michael P Jones; Sarah Wessinger; Michael D Crowell
Journal:  Clin Gastroenterol Hepatol       Date:  2006-04       Impact factor: 11.382

Review 6.  Irritable bowel syndrome: epidemiology, diagnosis and treatment: an update for health-care practitioners.

Authors:  Oliver Grundmann; Saunjoo L Yoon
Journal:  J Gastroenterol Hepatol       Date:  2010-01-13       Impact factor: 4.029

7.  The role of self-blame and responsibility in adjustment to inflammatory bowel disease.

Authors:  Jennifer Voth; Fuschia M Sirois
Journal:  Rehabil Psychol       Date:  2009-02

8.  Cognitive-behavioral therapy for irritable bowel syndrome: a meta-analysis.

Authors:  Li Li; Lishou Xiong; Shenghong Zhang; Qiao Yu; Minhu Chen
Journal:  J Psychosom Res       Date:  2014-03-26       Impact factor: 3.006

Review 9.  Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis.

Authors:  Guillaume Fond; Anderson Loundou; Nora Hamdani; Wahid Boukouaci; Aroldo Dargel; José Oliveira; Matthieu Roger; Ryad Tamouza; Marion Leboyer; Laurent Boyer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-04-06       Impact factor: 5.270

10.  The association between stressful life events and depressive symptoms among Cypriot university students: a cross-sectional descriptive correlational study.

Authors:  Sokratis Sokratous; Anastasios Merkouris; Nicos Middleton; Maria Karanikola
Journal:  BMC Public Health       Date:  2013-12-05       Impact factor: 3.295

View more
  2 in total

1.  Coping behaviors and depressive status in individuals with type 2 diabetes mellitus.

Authors:  Norio Yasui-Furukori; Hiroshi Murakami; Hideyuki Otaka; Hirofumi Nakayama; Masaya Murabayashi; Satoru Mizushiri; Koki Matsumura; Jutaro Tanabe; Yuki Matsuhashi; Miyuki Yanagimachi; Kazuhiko Nakamura; Makoto Daimon; Norio Sugawara
Journal:  Ann Gen Psychiatry       Date:  2019-07-17       Impact factor: 3.455

2.  Association between insomnia and coping style in Japanese patients with type 2 diabetes mellitus.

Authors:  Kazutaka Yoshida; Hideyuki Otaka; Hiroshi Murakami; Hirofumi Nakayama; Masaya Murabayashi; Satoru Mizushiri; Koki Matsumura; Jutaro Tanabe; Yuki Matsuhashi; Miyuki Yanagimachi; Norio Sugawara; Kazuhiko Nakamura; Makoto Daimon; Norio Yasui-Furukori
Journal:  Neuropsychiatr Dis Treat       Date:  2018-07-10       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.